Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications

Research output: Contribution to journal › Article › peer-review

2 Downloads (Pure)

Original language	English
Pages (from-to)	475-482
Journal	Expert Opinion on Investigational Drugs
Volume	31
Issue number	5
Early online date	23 Mar 2022
DOIs	https://doi.org/10.1080/13543784.2022.2054325
Publication status	Published - 2022

Keywords

@article{6e214cdc0bb2418f9d36b7fd73c1066f,

title = "Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications",

keywords = "Biological sciences",

author = "Jose Garrido-Mesa and Kate Adams and Julio Galvez and Natividad Garrido-Mesa",

year = "2022",

doi = "10.1080/13543784.2022.2054325",

language = "English",

volume = "31",

pages = "475--482",

journal = "Expert Opinion on Investigational Drugs",

issn = "1354-3784",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

TY - JOUR

T1 - Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19

T2 - a critical discussion of recent publications

AU - Garrido-Mesa, Jose

AU - Adams, Kate

AU - Galvez, Julio

AU - Garrido-Mesa, Natividad

PY - 2022

Y1 - 2022

KW - Biological sciences

U2 - 10.1080/13543784.2022.2054325

DO - 10.1080/13543784.2022.2054325

M3 - Article

SN - 1354-3784

VL - 31

SP - 475

EP - 482

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

IS - 5

ER -